| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $4.37B | -6.1% |
| Cost of Revenue | $2.83B | -4.9% |
| Gross Profit | $1.54B | -8.2% |
| R&D Expense | $112.2M | -8.4% |
| SG&A Expense | $468.0M | -10.4% |
| Operating Income | $112.9M | -25.7% |
| Pre-tax Income | -$80.7M | -872.3% |
| Income Tax | $80.0M | +2151.3% |
| Net Income | -$171.8M |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Accounts Receivable | $642.3M | -13.2% |
| Inventory | $1.08B | -5.2% |
| Current Assets | $2.48B | -12.4% |
| Total Assets | $9.65B | -10.7% |
| Current Liabilities | $1.04B | -34.2% |
| Long-term Debt | $3.58B | -1.4% |
| Total Liabilities | $5.33B | -11.8% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $362.9M | -10.5% |
| Capital Expenditures | $118.3M | +16.3% |
| Investing Cash Flow | $78.8M | +201.7% |
| Financing Cash Flow | -$611.0M | -226.4% |
| Free Cash Flow | $244.6M | -19.5% |
| -1252.8% |
| EPS (Basic) | -$1.25 | -1288.9% |
| EPS (Diluted) | -$1.25 | -1288.9% |
| Stockholders' Equity |
| $4.32B |
| -9.4% |